{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:15:28Z","timestamp":1789445728522,"version":"build-2803163510"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T00:00:00Z","timestamp":1471305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0160893","type":"journal-article","created":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T17:41:24Z","timestamp":1471369284000},"page":"e0160893","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress, Inflammation, Disease Severity, and Mortality during ICU Admission in Critically Ill Patients: Results from a Prospective Pilot Study"],"prefix":"10.1371","volume":"11","author":[{"given":"John H.","family":"Meertens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans L.","family":"Nienhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joop D.","family":"Lefrandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casper G.","family":"Schalkwijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristiina","family":"Nyyss\u00f6nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack J. M.","family":"Ligtenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andries J.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan G.","family":"Zijlstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. J.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,8,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/00003246-199206000-00025","article-title":"American College of Chest Physicians\/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis","volume":"20","year":"1992","journal-title":"Crit Care Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/MCO.0b013e3282f0c97c","article-title":"Markers of oxidative stress in ICU clinical settings: present and future","volume":"10","author":"T Grune","year":"2007","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20061131","article-title":"Oxidative stress and cancer: have we moved forward?","volume":"401","author":"B Halliwell","year":"2007","journal-title":"Biochem J"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1097\/01.CCM.0000055371.27268.36","article-title":"Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome","volume":"31","author":"T Motoyama","year":"2003","journal-title":"Critical care medicine"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1097\/00003246-200006000-00021","article-title":"Plasma redox status relates to severity in critically ill patients","volume":"28","author":"JM Alonso de Vega","year":"2000","journal-title":"Crit Care Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/35041687","article-title":"Oxidants, oxidative stress and the biology of ageing","volume":"408","author":"T Finkel","year":"2000","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF01910730","article-title":"The Maillard reaction in vivo","volume":"30","author":"DG Dyer","year":"1991","journal-title":"Z Ernahrungswiss"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1172\/JCI3042","article-title":"The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation","volume":"104","author":"MM Anderson","year":"1999","journal-title":"J Clin Invest"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"9982","DOI":"10.1074\/jbc.271.17.9982","article-title":"The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions","volume":"271","author":"MX Fu","year":"1996","journal-title":"J Biol Chem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1172\/JCI116481","article-title":"Accumulation of Maillard reaction products in skin collagen in diabetes and aging","volume":"91","author":"DG Dyer","year":"1993","journal-title":"J Clin Invest"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/01.RES.84.5.489","article-title":"Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis","volume":"84","author":"AM Schmidt","year":"1999","journal-title":"Circ Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.2174\/0929867043364342","article-title":"The clinical relevance of advanced glycation endproducts (AGE) and recent developments in pharmaceutics to reduce AGE accumulation","volume":"11","author":"AJ Smit","year":"2004","journal-title":"Curr Med Chem"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/cc6187","article-title":"Targeting RAGE in sepsis","volume":"12","author":"MA van Zoelen","year":"2008","journal-title":"Crit Care"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1189\/jlb.1008646","article-title":"AGE-modified albumin containing infusion solutions boosts septicaemia and inflammation in experimental peritonitis","volume":"86","author":"PM Humpert","year":"2009","journal-title":"J Leukoc Biol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1172\/JCI200418704","article-title":"Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response","volume":"113","author":"B Liliensiek","year":"2004","journal-title":"J Clin Invest"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1472-6890-10-4","article-title":"Accumulation of advanced glycation end (AGEs) products in intensive care patients: an observational, prospective study","volume":"10","author":"WL Greven","year":"2010","journal-title":"BMC Clin Pathol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.phrs.2009.05.002","article-title":"Circulating levels of advanced glycation end products (AGE) and interleukin-6 (IL-6) are independent determinants of serum asymmetric dimethylarginine (ADMA) levels in patients with septic shock","volume":"60","author":"T Nakamura","year":"2009","journal-title":"Pharmacol Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"R135","DOI":"10.1186\/cc5048","article-title":"Accuracy and feasibility of point-of-care and continuous blood glucose analysis in critically ill ICU patients","volume":"10","author":"AM Corstjens","year":"2006","journal-title":"Crit Care"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine","volume":"22","author":"JL Vincent","year":"1996","journal-title":"Intensive Care Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1089\/dia.2006.8.523","article-title":"Skin autofluorescence, a novel marker for glycemic and oxidative stress-derived advanced glycation endproducts: an overview of current clinical studies, evidence, and limitations","volume":"8","author":"DJ Mulder","year":"2006","journal-title":"Diabetes Technol Ther"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1196\/annals.1333.036","article-title":"Simple noninvasive measurement of skin autofluorescence","volume":"1043","author":"R Meerwaldt","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"ref22","first-page":"111","article-title":"Instrumentation for the measurement of autofluorescence in human skin","volume":"5692","author":"R Graaff","year":"2005","journal-title":"Proc SPIE Int Soc Opt Eng"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s00125-004-1451-2","article-title":"Simple non-invasive assessment of advanced glycation endproduct accumulation","volume":"47","author":"R Meerwaldt","year":"2004","journal-title":"Diabetologia"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1681\/ASN.2005020144","article-title":"Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients","volume":"16","author":"R Meerwaldt","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1007\/s10545-007-0507-0","article-title":"Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia","volume":"30","author":"NC den Hollander","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/aor.12205","article-title":"Skin and plasma autofluorescence during hemodialysis: a pilot study","volume":"38","author":"R Graaff","year":"2014","journal-title":"Artif Organs"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jhep.2011.07.028","article-title":"Endogenous formation of Nepsilon-(carboxymethyl)lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosis","volume":"56","author":"KH Gaens","year":"2012","journal-title":"J Hepatol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"E1369","DOI":"10.1210\/jc.2013-1068","article-title":"Plasma levels of advanced glycation endproducts Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studies","volume":"98","author":"NM Hanssen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.atherosclerosis.2009.10.007","article-title":"Lycopene, lutein and beta-carotene as determinants of LDL conjugated dienes in serum","volume":"209","author":"J Karppi","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref30","article-title":"Enhanced skin autofluorescence as a marker for oxidative stress in sepsis, a pilot study","volume":"30","author":"DJ Mulder","year":"2004","journal-title":"Intens Care Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/BF03086239","article-title":"Skin autofluorescence is elevated in acute myocardial infarction and is associated with the one-year incidence of major adverse cardiac events","volume":"17","author":"DJ Mulder","year":"2009","journal-title":"Neth Heart J"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/ndt\/gfn634","article-title":"AGEs, autofluorescence and renal function","volume":"24","author":"EG Gerrits","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/j.1582-4934.2009.00803.x","article-title":"Methylglyoxal modulates immune responses: relevance to diabetes","volume":"14","author":"CL Price","year":"2010","journal-title":"J Cell Mol Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1365-2362.2012.02694.x","article-title":"Plasma glycation levels are associated with severity in sepsis","volume":"42","author":"ME Andrades","year":"2012","journal-title":"Eur J Clin Invest"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/ndt\/gfg619","article-title":"Increased levels of N(epsilon)-(carboxymethyl)lysine and N(epsilon)-(carboxyethyl)lysine in type 1 diabetic patients with impaired renal function: correlation with markers of endothelial dysfunction","volume":"19","author":"ML Lieuw-A-Fa","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/ajkd.2001.27695","article-title":"N(epsilon)-(carboxymethyl)lysine levels in patients with type 2 diabetes: role of renal function","volume":"38","author":"Z Wagner","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehm486","article-title":"Clinical and prognostic value of advanced glycation end-products in chronic heart failure","volume":"28","author":"JW Hartog","year":"2007","journal-title":"Eur Heart J"},{"key":"ref38","first-page":"387","article-title":"Decreased levels of advanced glycation end-products in patients with Gilbert syndrome","volume":"51","author":"M Kalousova","year":"2005","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cca.2012.08.029","article-title":"Lower carotid intima media thickness is predicted by higher serum bilirubin in both non-diabetic and Type 2 diabetic subjects","volume":"414","author":"RP Dullaart","year":"2012","journal-title":"Clin Chim Acta"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/SHK.0b013e318217025a","article-title":"2nd. Plasma biomarkers of oxidant stress and development of organ failure in severe sepsis","volume":"36","author":"LB Ware","year":"2011","journal-title":"Shock"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jss.2007.07.014","article-title":"sRAGE is elevated in septic patients and associated with patients outcome","volume":"147","author":"C Bopp","year":"2008","journal-title":"J Surg Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1164\/rccm.200509-1477OC","article-title":"Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury","volume":"173","author":"T Uchida","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1136\/thx.2008.095588","article-title":"Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury","volume":"63","author":"CS Calfee","year":"2008","journal-title":"Thorax"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3109\/00365513.2013.849357","article-title":"Soluble receptor for advanced glycation end products predicts 28-day mortality in critically ill patients with sepsis","volume":"73","author":"H Brodska","year":"2013","journal-title":"Scand J Clin Lab Invest"},{"key":"ref45","first-page":"917108","article-title":"The Receptor for Advanced Glycation End Products (RAGE) and the Lung","volume":"2010","author":"ST Buckley","year":"2010"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1053\/j.ajkd.2005.12.028","article-title":"Soluble receptor for advanced glycation end products in patients with decreased renal function","volume":"47","author":"M Kalousova","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1196\/annals.1333.075","article-title":"Plasma levels of AGE peptides in type 1 diabetic patients are associated with serum creatinine and not with albumin excretion rate: possible role of AGE peptide-associated endothelial dysfunction","volume":"1043","author":"CG Schalkwijk","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/ndt\/gfi309","article-title":"Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals","volume":"21","author":"F Stam","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/MCA.0b013e3282fec058","article-title":"Plasma N-epsilon-(carboxymethyl)lysine levels are associated with the extent of vessel injury after coronary arterial stenting","volume":"19","author":"G Basta","year":"2008","journal-title":"Coron Artery Dis"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1161\/ATVBAHA.115.306106","article-title":"Protein-Bound Plasma Nepsilon-(Carboxymethyl)lysine Is Inversely Associated With Central Obesity and Inflammation and Significantly Explain a Part of the Central Obesity-Related Increase in Inflammation: The Hoorn and CODAM Studies","volume":"35","author":"KH Gaens","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1378\/chest.123.6.2043","article-title":"C-reactive protein levels correlate with mortality and organ failure in critically ill patients","volume":"123","author":"SM Lobo","year":"2003","journal-title":"Chest"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/cc306","article-title":"Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS","volume":"3","author":"M Meisner","year":"1999","journal-title":"Crit Care"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1053\/j.ajkd.2005.10.010","article-title":"Serum carboxymethyllysine predicts mortality in hemodialysis patients","volume":"47","author":"Z Wagner","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1523-1755.2002.00423.x","article-title":"Advanced glycation end products and mortality in hemodialysis patients","volume":"62","author":"SB Schwedler","year":"2002","journal-title":"Kidney Int"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s00134-010-1873-x","article-title":"Infusion fluids contain harmful glucose degradation products","volume":"36","author":"A Bryland","year":"2010","journal-title":"Intensive Care Med"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3747\/pdi.2010.00009","article-title":"The influence of bicarbonate\/lactate-buffered PD fluids on N{epsilon}-(carboxyethyl)lysine and N{epsilon}-(carboxymethyl)lysine in peritoneal effluent","volume":"31","author":"TT Cnossen","year":"2011","journal-title":"Perit Dial Int"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0160893","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T06:12:26Z","timestamp":1601014346000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0160893"}},"subtitle":[],"editor":[{"given":"Ram","family":"Nagaraj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,8,16]]},"references-count":56,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0160893","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,16]]}}}